The funding comes from the same investors who poured $7.6 million into the company last year to restart the company, including Warburg Pincus, Kaiser Permanente Ventures and the Vertical Group. This comes after significant financing in previous years, totaling a reported $40 million. Earlier investors Three Arch Partners and De Novo Ventures have passed on reinvesting, VentureWire said.